These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3298932)

  • 21. Patient profile and effect of dietary therapy on post-transplant hyperlipidemia.
    Shen SY; Lukens CW; Alongi SV; Sfeir RE; Dagher FJ; Sadler JH
    Kidney Int Suppl; 1983 Dec; 16():S147-52. PubMed ID: 6376913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperlipidemia in renal transplant recipients: natural history and response to treatment.
    Ong CS; Pollock CA; Caterson RJ; Mahony JF; Waugh DA; Ibels LS
    Medicine (Baltimore); 1994 Jul; 73(4):215-23. PubMed ID: 8041244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of multiple pharmaco-therapy in the pathogenesis of hyperlipidemia after renal transplantation.
    Chan MK; Varghese Z; Persaud JW; Fernando ON; Moorhead JF
    Clin Nephrol; 1981 Jun; 15(6):309-13. PubMed ID: 6113904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid disturbances before and after renal transplant.
    Razeghi E; Shafipour M; Ashraf H; Pourmand G
    Exp Clin Transplant; 2011 Aug; 9(4):230-5. PubMed ID: 21819366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperlipidemia after heart transplantation.
    Keogh A; Simons L; Spratt P; Esmore D; Chang V; Hickie J; Baron D
    J Heart Transplant; 1988; 7(3):171-5. PubMed ID: 3290399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
    Seymen P; Yildiz M; Türkmen MF; Titiz MI; Seymen HO
    Transplant Proc; 2009 Dec; 41(10):4181-3. PubMed ID: 20005364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperlipidemia in stable renal transplant recipients.
    Divakar D; Bailey RR; Frampton CM; George PM; Walmsley TA; Murphy J
    Nephron; 1991; 59(3):423-8. PubMed ID: 1758532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients.
    Vathsala A; Weinberg RB; Schoenberg L; Grevel J; Goldstein RA; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1989 Jul; 48(1):37-43. PubMed ID: 2665233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum homocysteine levels in renal transplant recipients with and without hypercholesterolemia.
    Piovesan F; Veronese FJ; Santos AF; Pozza R; Sarturi PS; Tognon A; Garcia VD; Keitel E; Saitovitch D
    Arq Bras Cardiol; 2007 Sep; 89(3):154-9, 170-5. PubMed ID: 17906816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on post-transplant dyslipidemia in kidney transplant patients.
    Marubayashi S; Ohdan H; Tashiro H; Tokita D; Onoe T; Hayamizu K; Asahara T; Doi S; Okumoto S; Tanji C; Kawai T; Taniguchi Y; Fukuda Y; Dohi K
    Hiroshima J Med Sci; 2005 Jun; 54(2):39-45. PubMed ID: 15991596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperlipidemia following renal transplantation.
    Ibels LS; Alfrey AC; Subryan V; Weil R
    Trans Am Soc Artif Intern Organs; 1976; 22():46-53. PubMed ID: 781985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperlipidemia after renal transplantation: treatment with gemfibrozil.
    Chan TM; Cheng IK; Tam SC
    Nephron; 1994; 67(3):317-21. PubMed ID: 7936022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dietary therapy on post renal transplant hyperlipidemia. A prospective study.
    Lal SM; Trivedi HS; Van Stone JC; Ross G
    Int J Artif Organs; 1994 Sep; 17(9):461-5. PubMed ID: 7890433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation.
    Spinelli GA; Felipe CR; Machado PG; Garcia R; Casarini DE; Moreira SR; Park SI; Tedesco-Silva H; Medina-Pestana JO
    Braz J Med Biol Res; 2006 Jan; 39(1):19-30. PubMed ID: 16400461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
    Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid disorders in renal transplant recipients.
    Ponticelli C; Barbi GL; Cantaluppi A; De Vecchi A; Annoni G; Donati C; Cecchettin M
    Nephron; 1978; 20(4):189-95. PubMed ID: 345139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperlipidemia after renal transplantation: natural history and pathophysiology.
    Cattran DC; Steiner G; Wilson DR; Fenton SA
    Ann Intern Med; 1979 Oct; 91(4):554-9. PubMed ID: 384859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
    Imamura R; Ichimaru N; Moriyama T; Shi Y; Namba Y; Nonomura N; Matsumiya K; Toki K; Takahara S; Okuyama A
    Clin Transplant; 2005 Oct; 19(5):616-21. PubMed ID: 16146552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lipid status in the physician's laboratory].
    Drexel H
    Ther Umsch; 1995 May; 52(5):340-2. PubMed ID: 7770820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.